Techno Trends
Techno Trends includes advancements and innovations in pharmaceutical products and technology from around the world. Additionally, you may keep abreast of any recent advancements in the pharmaceutical industry (product information and technological trends).
Kura Oncology's Ziftomenib Receives FDA Breakthrough Designation for NPM1-Mutant AML
Kura Oncology, has received Breakthrough Therapy Designation from FDA for their experimental drug, ziftomenib. This designation is for treating patients with relapsed or refractory NPM1-mutant acute myeloid leukemia (AML)....
Merck Reveals a Breakthrough in Biosafety Testing Efficiency with Its All-in-One Genetic Stability Assay
The Merck has reveal Aptegra™ CHO genetic stability assay, a groundbreaking all-in-one solution that enhances biosafety testing. This innovative assay uses whole genome sequencing and bioinformatics...
FDA Approves CARVYKTI® Breakthrough Therapy for Second-Line Multiple Myeloma
Legend Biotech Corporation has developed CARVYKTI®, a breakthrough therapy approved by the U.S. Food and Drug Administration for treating relapsed or refractory multiple myeloma....
FDA Approves Breyanzi® as First-of-Its-Kind Cell Therapy for Relapsed/Refractory CLL/SLL
Bristol Myers Squibb has recently announced the U.S. Food and Drug Administration accelerated approval of Breyanzi®, a CD19-directed chimeric antigen receptor...
UChicago Medicine to Offer Groundbreaking Treatment for Rare Metabolic Liver Disease
The University of Chicago Medicine is set to prescribe Resmetirom, a groundbreaking drug marketed as Rezdiffra. For the treatment of advanced metabolic dysfunction-associated steatotic liver disease...
First-of-Its-Kind Antibiotic-Resistant Bacteria Drugs Developed Using Generative AI
Researchers at Stanford Medicine and McMaster University are addressing the global challenge of antibiotic resistance using generative artificial intelligence....
RYBREVANT® Combination Therapy Novel FDA Approval for First-Line Non-Small Cell Lung Cancer Treatment
Johnson & Johnson revealed that the U.S. Food and Drug Administration has granted approval for the use of RYBREVANT® in combination with chemotherapy as a first-line treatment for patients diagnosed...
Novel WINREVAIR™ Receives FDA Approval as First-in-Class Treatment for Adults with Pulmonary Arterial Hypertension
Merck, has announced that the U.S. Food and Drug Administration (FDA) has granted approval for sotatercept-csrk under the brand name WINREVAIR™. ...
UCF Researchers Unveil Revolutionary Treatment for Untreatable Brain Cancer
Researchers at the College of Medicine are pioneering a new approach to combat glioblastoma, an aggressive and currently incurable form of brain cancer. Despite existing treatments such as surgery, radiation, and chemotherapy, patients typically face a grim...
Biogen's SKYCLARYS® Receives Groundbreaking European Commission Approval as the First Treatment for Friedreich’s Ataxia
Biogen recently announced a groundbreaking development: the European Commission has officially authorized SKYCLARYS® for treating Friedreich’s ataxia in adults and adolescents aged 16 years and older. This marks a significant step forward as...
